Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832598 · ClinicalTrials.gov registry record · NA
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00832598: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00832598 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832598, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to help us understand gliomas, one type of brain tumor. This research protocol makes pictures of gliomas. We will take pictures of the glioma before and after treatment. The pictures are made with a positron emission tomography (PET) scanner. PET scans use radioactive markers to "see" cancer cells. We plan to use two different radioactive markers, \[18F\]FACBC and \[18F\]FLT, to "see" if the glioma responds to the treatment being recommended by the doctor. We are investigating whether one or both of these types of PET scans can help us to better understand gliomas and their response to treatment. We expect these pictures will give us information the your tumor and may help us to understand why the treatment that the patient is receiving is affecting the tumor the way that it is. We also hope to collect information about the amount of radioactivity exposure. We will measure radioactivity exposure to the tumor, brain and other organs.
Interventions
- RADIATION [18F]FACBC PET and [18F]FLT PET imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-01 |
| Est. Completion | 2017-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832598
The ClinicalTrials.gov registry entry for NCT00832598 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]FACBC PET and [18F]FLT PET imaging is the first listed.
NCT00832598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832598 about?
NCT00832598 is a clinical study titled "[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors". The purpose of this study is to help us understand gliomas, one type of brain tumor. This research protocol makes pictures of gliomas. We will take pictures of the glioma before and after treatment. The pictures are made with a positron emission tomography (PET) scanner. PET scans use radioactive ma...
What is the current status of trial NCT00832598?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-01. Estimated completion is 2017-03-21.
What interventions are being tested in trial NCT00832598?
The interventions under investigation include: [18F]FACBC PET and [18F]FLT PET imaging (RADIATION).
Who is sponsoring clinical trial NCT00832598?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.